Oramed Pharmaceuticals In...

NASDAQ: ORMP · Real-Time Price · USD
2.08
-0.04 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
2.07
-0.48%
After-hours: Aug 15, 2025, 05:49 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Aug 31, 2021
PE Ratio
16.86 -12.42 -25.19
PEG Ratio
-0.15 -0.51 -0.64
PS Ratio
69.50 173.56 207.28
PB Ratio
0.57 3.09 4.84
P/FCF Ratio
-8.83 -16.51 -25.99
P/OCF Ratio
-9.05 -16.8 -26.45
OCF/S Ratio
-7.68 -10.33 -7.84
Debt / Equity Ratio
0.32 0.01 0.00
Quick Ratio
3.06 27.34 14.27
Current Ratio
3.06 27.34 14.27
Asset Turnover
0.01 0.02 0.02
Interest Coverage
-4.4 n/a -4.04K
Return on Equity
0.03 -0.25 -0.19
Return on Assets
0.03 -0.23 -0.17
Return on Invested Capital
-0.07 -0.26 -0.17
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
1.00 1.00 1.00
Net Profit Margin
4.12 -13.97 -8.23
Pretax Profit Margin
3.80 -13.93 -8.5
Operating Profit Margin
-11.77 -15.02 -8.96
FCF Margin
n/a n/a n/a
EBITDA Margin
-11.62 -13.68 -9.26